Avidan U. Neumann - Concepedia

Author

Avidan U. Neumann

Also Known As

A NEUMANN, A Neumann, A U Neumann, A. Neumann, A. U. NEUMANN, A. U. Neumann, A.U Neumann, A.U. Neumann, AVIDAN U. NEUMANN, Avidan Neumann

230

Publications

22.7K

Citations

H-Index

139

Concepts

All Affiliations

Bar-Ilan University Charité - Universitätsmedizin Berlin Helmholtz Zentrum München Los Alamos National Laboratory Université Paris-Est Créteil

About

Avidan U. Neumann is an author at Bar-Ilan University specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	58	11.1K
2	Engineering	4	4	255
3	Business	2	2	52
4	Public Health	2	2	247
5	Health Sciences	1	1	131

Avidan U. Neumann

125

Publications

22.1K

Citations

H-Index

Page 1

	Year	Citations
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection David D. Ho, Avidan U. Neumann, Alan S. Perelson, Nature Plasma VirionsViral PersistenceHuman RetrovirusImmunologyAntiviral Response	1995	4.3K
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time Alan S. Perelson, Avidan U. Neumann, Martin Markowitz, Science	1996	3.5K
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy Avidan U. Neumann, Nancy P. Lam, Harel Dahari, Science	1998	2.1K
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression Yaoxing Huang, William A. Paxton, Steven M. Wolinsky, Nature Medicine Primary ImmunodeficiencyDisease ProgressionHuman RetrovirusImmunodeficienciesHiv–1 Transmission	1996	1.4K
Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection Steven M. Wolinsky, Bette Korber, Avidan U. Neumann, Science Primary ImmunodeficiencyHuman RetrovirusPathogenesisImmunologyViral Dynamic	1996	570
Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors Urszula Radzikowska, Mei Ding, Ge Tan, Allergy	2020	568
Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy Guy Gorochov, Avidan U. Neumann, Anne Kereveur, Nature Medicine Adaptive Immune SystemHuman RetrovirusImmunologyAntiviral ResponseAntiviral Therapy	1998	426
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation Leondios G. Kostrikis, Yaoxing Huang, John P. Moore, Nature Medicine Primary ImmunodeficiencyCcr5 Promoter MutationHuman RetrovirusImmunologyAntiviral Response	1998	395
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa Natalie Lam, Avidan U. Neumann, David R. Gretch, Hepatology	1997	329
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial Emma Guttman‐Yassky, Patrick M. Brunner, Avidan U. Neumann, Journal of the American Academy of Dermatology	2018	328

Page 1